Roger A. Pedersen
Corporate Officer/Principal bei University of Cambridge
Profil
Roger A.
Pedersen is the founder of DefiniGEN Ltd.
which was founded in 2012.
Currently, he is a Professor at the University of Cambridge.
Dr. Pedersen completed his undergraduate degree from Stanford University in 1965 and his doctorate degree from Yale University in 1970.
Aktive Positionen von Roger A. Pedersen
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Roger A. Pedersen
| Unternehmen | Position | Ende |
|---|---|---|
DefiniGEN Ltd.
 DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Gründer | - |
Ausbildung von Roger A. Pedersen
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
